Molecular basis of delta beta-thalassemia with normal fetal hemoglobin level [letter]

Blood ◽  
1990 ◽  
Vol 75 (2) ◽  
pp. 526-528
Author(s):  
G Loudianos ◽  
A Cao ◽  
MS Ristaldi ◽  
M Pirastu ◽  
M Tzeti ◽  
...  
Blood ◽  
1990 ◽  
Vol 75 (2) ◽  
pp. 526-528 ◽  
Author(s):  
G Loudianos ◽  
A Cao ◽  
MS Ristaldi ◽  
M Pirastu ◽  
M Tzeti ◽  
...  

2020 ◽  
Vol 9 (1) ◽  
Author(s):  
Shira Raviv ◽  
Alon Shrim ◽  
Julia Eidel ◽  
Yoav Yinon ◽  
Boaz Weiz ◽  
...  

Abstract Objectives Chorioangiomas (CAs) are the most frequent tumor-like-lesions of the placenta. Giant CAs (more than 4–5 cm in diameter) is rare and may result in severe maternal fetal complications. Case presentation A 38-year-old multigravida presented at 31 weeks’ gestation with contractions. Upon evaluation, contractions were spontaneously ceased, and the cervix was closed. Ultrasound examination revealed a single viable fetus, polyhydramnios and a 75 x 48 x 82 mm vascular lesion located on the placental surface near the cord insertion. Doppler assessment was suggestive of fetal anemia with middle cerebral artery-peak systolic velocity (MCA-PSV) 1.8 MoM’s. Fetal heart rate monitoring and biophysical scores were reassuring. Following betamethasone fetal cord sampling that revealed fetal hemoglobin level of 8.8 g/dL, 57 cc of blood was transfused resulting in final hemoglobin level of 14.3 g/dL measured prior to needle extraction. MCA-PSV was normalized immediately after the procedure, however aggravated at the following day with MCA-PSV 65 cm/s (1.46 MoM’s). No other intervention was taken and MCA-PSV continued to fluctuate from slight to severe anemia spontaneously over a period of two weeks. At 34 gestational weeks, the women delivered a healthy baby. Fetal hemoglobin level at delivery was 21 g/dL. Conclusions Fetal blood transfusion is a reasonable treatment for fetal anemia in cases of giant chorioangiomas. Following transfusion, MCA-PSV may act unexpectedly reflecting various mechanisms affecting the flow.


Author(s):  
Julia Ye. Leonova ◽  
Elena G. Kazanetz ◽  
Natalia S. Smetanina ◽  
Adekunle D. Adekile ◽  
Georgi D. Efremov ◽  
...  

Science ◽  
2013 ◽  
Vol 342 (6155) ◽  
pp. 253-257 ◽  
Author(s):  
D. E. Bauer ◽  
S. C. Kamran ◽  
S. Lessard ◽  
J. Xu ◽  
Y. Fujiwara ◽  
...  

2011 ◽  
Vol 07 (01) ◽  
pp. 64
Author(s):  
Samir K Ballas ◽  
Robert L Bauserman ◽  
William F McCarthy ◽  
Myron A Waclawiw ◽  
◽  
...  

Some genetic markers known to play a role in sickle cell disease were associated with classification as a treatment responder, pain-related outcomes, and equi-analgesic dosing in the Multicenter Study of Hydroxurea (MSH) cohort. However, when examined by sex, associations with equi-analgesic dosing were statistically significant for males only. Factors that increase the hemoglobin/hematocrit levels seem not to be beneficial. Future research should focus on factors that increase fetal hemoglobin level.


2020 ◽  
Vol 66 (01+02/2020) ◽  
Author(s):  
GoEun Kwon ◽  
Aya Okahashi ◽  
Nobuhiko Nagano ◽  
Chihiro Nozaki ◽  
Erina Nakahara ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document